Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Double-blind, Randomized, Multicenter Study Evaluating 200 mg Versus 600 mg of Mifegyne® on Pain in Medical Termination of Pregnancy (MToP) up to 7 Weeks of Amenorreha (WA). DoMy Study.

Next Previous
Trial Profile

Double-blind, Randomized, Multicenter Study Evaluating 200 mg Versus 600 mg of Mifegyne® on Pain in Medical Termination of Pregnancy (MToP) up to 7 Weeks of Amenorreha (WA). DoMy Study.

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Sep 2018

At a glance

  • Drugs Mifepristone (Primary)
  • Indications Induced abortion
  • Focus Therapeutic Use
  • Acronyms DoMy

    • Most Recent Events

    • 13 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top